Cargando…

Stable gastric pentadecapeptide BPC 157 can improve the healing course of spinal cord injury and lead to functional recovery in rats

BACKGROUND: We focused on the therapeutic effects of the stable gastric pentadecapeptide BPC 157 in spinal cord injury using a rat model. BPC 157, of which the LD1 has not been achieved, has been implemented as an anti-ulcer peptide in inflammatory bowel disease trials and recently in a multiple scl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perovic, Darko, Kolenc, Danijela, Bilic, Vide, Somun, Nenad, Drmic, Domagoj, Elabjer, Esmat, Buljat, Gojko, Seiwerth, Sven, Sikiric, Predrag
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6604284/ https://www.ncbi.nlm.nih.gov/pubmed/31266512 http://dx.doi.org/10.1186/s13018-019-1242-6

Ejemplares similares

Salutary effect of gastric pentadecapeptide BPC 157 in two different stress urinary incontinence models in female rats
por: Jandric, Ivan, et al.
Publicado: (2013)

The effect of pentadecapeptide BPC 157 on hippocampal ischemia/reperfusion injuries in rats
por: Vukojević, Jakša, et al.
Publicado: (2020)

Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications
por: Sikiric, Predrag, et al.
Publicado: (2016)

Novel Therapeutic Effects in Rat Spinal Cord Injuries: Recovery of the Definitive and Early Spinal Cord Injury by the Administration of Pentadecapeptide BPC 157 Therapy
por: Perovic, Darko, et al.
Publicado: (2022)

Effects of Diclofenac, L-NAME, L-Arginine, and Pentadecapeptide BPC 157 on Gastrointestinal, Liver, and Brain Lesions, Failed Anastomosis, and Intestinal Adaptation Deterioration in 24 Hour-Short-Bowel Rats
por: Lojo, Nermin, et al.
Publicado: (2016)

Pentadecapeptide BPC 157 Reduces Bleeding and Thrombocytopenia after Amputation in Rats Treated with Heparin, Warfarin, L-NAME and L-Arginine
por: Stupnisek, Mirjana, et al.
Publicado: (2015)

Stable Gastric Pentadecapeptide BPC 157 and Wound Healing
por: Seiwerth, Sven, et al.
Publicado: (2021)

Pentadecapeptide BPC 157 and the central nervous system
por: Vukojević, Jakša, et al.
Publicado: (2021)

Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insights
por: Duzel, Antonija, et al.
Publicado: (2017)

Bowel adhesion and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine in rats
por: Cesar, Lidija Berkopic, et al.
Publicado: (2020)

Stable Gastric Pentadecapeptide BPC 157 as a Therapy for the Disable Myotendinous Junctions in Rats
por: Japjec, Mladen, et al.
Publicado: (2021)

Stable Gastric Pentadecapeptide BPC 157 Therapy of Rat Glaucoma
por: Kralj, Tamara, et al.
Publicado: (2021)

Occluded Superior Mesenteric Artery and Vein. Therapy with the Stable Gastric Pentadecapeptide BPC 157
por: Knezevic, Mario, et al.
Publicado: (2021)

Stable Gastric Pentadecapeptide BPC 157 Therapy for Monocrotaline-Induced Pulmonary Hypertension in Rats Leads to Prevention and Reversal
por: Udovicic, Mario, et al.
Publicado: (2021)

Pentadecapeptide BPC 157 shortens duration of tetracaine- and oxybuprocaine-induced corneal anesthesia in rats
por: Mirković, Ivan, et al.
Publicado: (2020)

Counteraction of perforated cecum lesions in rats: Effects of pentadecapeptide BPC 157, L-NAME and L-arginine
por: Drmic, Domagoj, et al.
Publicado: (2018)

Stable Gastric Pentadecapeptide BPC 157 and Striated, Smooth, and Heart Muscle
por: Staresinic, Mario, et al.
Publicado: (2022)

In relation to NO-System, Stable Pentadecapeptide BPC 157 Counteracts Lidocaine-Induced Adverse Effects in Rats and Depolarisation In Vitro
por: Lozic, Marin, et al.
Publicado: (2020)

Stable Gastric Pentadecapeptide BPC 157 Heals Established Vesicovaginal Fistula and Counteracts Stone Formation in Rats
por: Rasic, Domagoj, et al.
Publicado: (2021)

Bypassing major venous occlusion and duodenal lesions in rats, and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine
por: Amic, Fedor, et al.
Publicado: (2018)

Stable Gastric Pentadecapeptide BPC 157, Robert’s Stomach Cytoprotection/Adaptive Cytoprotection/Organoprotection, and Selye’s Stress Coping Response: Progress, Achievements, and the Future
por: Sikiric, Predrag, et al.
Publicado: (2020)

Over-Dose Lithium Toxicity as an Occlusive-like Syndrome in Rats and Gastric Pentadecapeptide BPC 157
por: Strbe, Sanja, et al.
Publicado: (2021)

Stable Gastric Pentadecapeptide BPC 157 Therapy for Primary Abdominal Compartment Syndrome in Rats
por: Tepes, Marijan, et al.
Publicado: (2021)

Celecoxib-induced gastrointestinal, liver and brain lesions in rats, counteraction by BPC 157 or L-arginine, aggravation by L-NAME
por: Drmic, Domagoj, et al.
Publicado: (2017)

Complex Syndrome of the Complete Occlusion of the End of the Superior Mesenteric Vein, Opposed with the Stable Gastric Pentadecapeptide BPC 157 in Rats
por: Knezevic, Mario, et al.
Publicado: (2021)

Corrigendum: Stable Gastric Pentadecapeptide BPC 157 Therapy for Primary Abdominal Compartment Syndrome in Rats
por: Tepes, Marijan, et al.
Publicado: (2022)

Stable Gastric Pentadecapeptide BPC 157 May Counteract Myocardial Infarction Induced by Isoprenaline in Rats
por: Barisic, Ivan, et al.
Publicado: (2022)

Stable Gastric Pentadecapeptide BPC 157—Possible Novel Therapy of Glaucoma and Other Ocular Conditions
por: Sikiric, Predrag, et al.
Publicado: (2023)

Pentadecapeptide BPC 157 resolves suprahepatic occlusion of the inferior caval vein, Budd-Chiari syndrome model in rats
por: Gojkovic, Slaven, et al.
Publicado: (2020)

Robert’s Intragastric Alcohol-Induced Gastric Lesion Model as an Escalated General Peripheral and Central Syndrome, Counteracted by the Stable Gastric Pentadecapeptide BPC 157
por: Gojkovic, Slaven, et al.
Publicado: (2021)

Antiarrhythmic Sotalol, Occlusion/Occlusion-like Syndrome in Rats, and Stable Gastric Pentadecapeptide BPC 157 Therapy
por: Premuzic Mestrovic, Ivica, et al.
Publicado: (2023)

Stable Gastric Pentadecapeptide BPC 157 May Recover Brain–Gut Axis and Gut–Brain Axis Function
por: Sikiric, Predrag, et al.
Publicado: (2023)

Stomach perforation-induced general occlusion/occlusion-like syndrome and stable gastric pentadecapeptide BPC 157 therapy effect
por: Kalogjera, Luka, et al.
Publicado: (2023)

Esophagogastric anastomosis in rats: Improved healing by BPC 157 and L-arginine, aggravated by L-NAME
por: Djakovic, Zeljko, et al.
Publicado: (2016)

Intragastric Application of Aspirin, Clopidogrel, Cilostazol, and BPC 157 in Rats: Platelet Aggregation and Blood Clot
por: Konosic, Sanja, et al.
Publicado: (2019)

Stable Gastric Pentadecapeptide BPC 157 Therapy: Effect on Reperfusion Following Maintained Intra-Abdominal Hypertension (Grade III and IV) in Rats
por: Tepes, Marijan, et al.
Publicado: (2023)

Therapy Effect of the Stable Gastric Pentadecapeptide BPC 157 on Acute Pancreatitis as Vascular Failure-Induced Severe Peripheral and Central Syndrome in Rats
por: Smoday, Ivan Maria, et al.
Publicado: (2022)

Fourier Transform Infrared Spectroscopy Reveals Molecular Changes in Blood Vessels of Rats Treated with Pentadecapeptide BPC 157
por: Gamulin, Ozren, et al.
Publicado: (2022)

Cytoprotective gastric pentadecapeptide BPC 157 resolves major vessel occlusion disturbances, ischemia-reperfusion injury following Pringle maneuver, and Budd-Chiari syndrome
por: Sikiric, Predrag, et al.
Publicado: (2022)

Physiological and Immunological Status of Adult Honeybees (Apis mellifera) Fed Sugar Syrup Supplemented with Pentadecapeptide BPC 157
por: Tlak Gajger, Ivana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0rd27029s3gcdpi764ds53jd8l